期刊文献+

阿克他利缓释片的研制及释放度考察 被引量:3

Preparation and release characteristics of actarit sustained-release tablets
下载PDF
导出
摘要 目的研究处方的组成和制备因素对阿克他利体外释放度的影响。方法以羟丙甲基纤维素(HPMC)为缓释材料,建立阿克他利缓释片的体外分析方法,通过测定累积溶出百分率对各种处方及工艺因素进行比较。结果 HPMC的黏度和用量、微晶纤维素的用量以及湿颗粒的粒径等因素均对主药的释放产生一定影响。对释药机制的考察表明,释药机制为混合机制,即扩散和溶蚀协同作用的结果。结论经处方筛选可以获得缓释效果较好的阿克他利缓释片。 Objective To study the effect of composition and preparation procedure of actarit sustained-release tablets on its release rate in vitro. Methods The analytical method in vitro of actarit sustained-release tablets with HPMC as the matrix material was set up and the effect of different formulation and preparation procedure on drug release was studied by determining the cumulative release. Results The release of actarit was affected by the viscosity and content of HPMC,the content of MCC and diameters of granules had effect on. The sustainedrelease mechanism of the tablets was also studied. It was showed that both diffusion and erosion had effects on the drug release. Conclusion Actarit sustained-release tablets with appropriate release rate can be obtained through formulation optimzation.
出处 《中国药剂学杂志(网络版)》 2004年第4期81-87,共7页 Chinese Journal of Pharmaceutics:Online Edition
关键词 药剂学 阿克他利 缓释片 释放度 pharmaceutics actarit sustained-release tablets cumulative release
  • 相关文献

参考文献5

二级参考文献9

共引文献64

同被引文献23

  • 1张翠娥,陈兴泉,刘鸿.对硝基苯乙酸还原反应的研究[J].应用化工,2004,33(4):55-56. 被引量:6
  • 2陈勇.对氨基苯乙酸的合成[J].安阳师范学院学报,2000(4):34-35. 被引量:5
  • 3韦长梅,嵇鸣.苯乙腈定向硝化制备对硝基苯乙腈[J].精细化工,2001,18(4):234-235. 被引量:5
  • 4倪楠,高永良.液体制剂中难溶性药物的增溶[J].中国新药杂志,2005,14(11):1276-1279. 被引量:11
  • 5Panagiotis B, Feras IK, Kyriakos K, et al. Artificial neural networks in the optimization of a nimodipine controlled release tablet formulation [J]. Eur J Pharm Biopharm, 2010, 74(2): 316-23.
  • 6Kozo T, Agnes M, Mikito F, et al. Formula optimiza- tion of theophylline controlled-release tablet based on artificial neural networks[J]. J Controlled Release, 2000, 68(2): 174-86.
  • 7NAKAMURA T, HIGASHI S, TOMODA K, et al. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis[J]. Rheumatology,2006,45 : 43 - 49.
  • 8TAKEBA Y, SUZUKI N, WAKISAtCA S, et al. Effect of aetarit on synovial cell functions with rheumatoid arthritis[J]. J Rheumatol, 1999,26 : 25 - 33.
  • 9NAKAMURA T, UEKI Y, SAKITO S, et al. Clinical effects of actarit in rheumatoid arthritis: improvement of early disease activity mediated by reduction of serum concentration of nitric oxide[J]. Clin Exp Rheumatol,2000,18:445 -450.
  • 10夏小琳.含有锌化合物和对乙酰氨基苯乙酸的组合物:中国,1166963A[P].1997-10-12.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部